ERK MAP kinase in G cell cycle progression and cancer (Q36519437)

14 August 2017

1 reference

title

ERK MAP kinase in G cell cycle progression and cancer (English)

1 reference

14 August 2017

Satoru Torii

1

1 reference

14 August 2017

Takuya Yamamoto

series ordinal

2

1 reference

14 August 2017

Yoshiki Tsuchiya

series ordinal

3

1 reference

14 August 2017

Eisuke Nishida

series ordinal

4

1 reference

14 August 2017

publication date

23 June 2006

1 reference

14 August 2017

1 reference

14 August 2017

volume

97

1 reference

14 August 2017

issue

8

1 reference

14 August 2017

page(s)

697-702

1 reference

Recent progress in characterization of protein kinase cascades for phosphorylation of ribosomal protein S6.

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00244.X

The MAP kinase cascade is essential for diverse signal transduction pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00244.X

Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00244.X

Mammalian MAP kinase signalling cascades

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00244.X

Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00244.X

The duration, magnitude and compartmentalization of ERK MAP kinase activity: mechanisms for providing signaling specificity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00244.X

Signaling networks that link cell proliferation and cell fate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00244.X

Targeting RAS signalling pathways in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00244.X

RAS and RHO GTPases in G1-phase cell-cycle regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00244.X

G1 cell-cycle control and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00244.X

sprouty encodes a novel antagonist of FGF signaling that patterns apical branching of the Drosophila airways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00244.X

Spred is a Sprouty-related suppressor of Ras signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00244.X

Sef is a feedback-induced antagonist of Ras/MAPK-mediated FGF signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00244.X

Identification of Sef, a novel modulator of FGF signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00244.X

Modulation of signalling by Sprouty: a developing story

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00244.X

Sprouty1 and Sprouty2 provide a control mechanism for the Ras/MAPK signalling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00244.X

Efficient suppression of FGF-2-induced ERK activation by the cooperative interaction among mammalian Sprouty isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00244.X

Mammalian Sprouty4 suppresses Ras-independent ERK activation by binding to Raf1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00244.X

Shp2, an SH2-containing protein-tyrosine phosphatase, positively regulates receptor tyrosine kinase signaling by dephosphorylating and inactivating the inhibitor Sprouty

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00244.X

Tyrosine phosphorylation of Sprouty proteins regulates their ability to inhibit growth factor signaling: a dual feedback loop

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00244.X

Sprouty proteins are in vivo targets of Corkscrew/SHP-2 tyrosine phosphatases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00244.X

Tyrosine phosphorylation of Sprouty2 enhances its interaction with c-Cbl and is crucial for its function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00244.X

hSpry2 is targeted to the ubiquitin-dependent proteasome pathway by c-Cbl

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00244.X

Sprouty fine-tunes EGF signaling through interlinked positive and negative feedback loops

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00244.X

Regulation of sprouty stability by Mnk1-dependent phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00244.X

Regulatory mechanisms and function of ERK MAP kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00244.X

Sef is a spatial regulator for Ras/MAP kinase signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00244.X

Cell cycle targets of Ras/Raf signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00244.X

Integrating the MAP kinase signal into the G1 phase cell cycle machinery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00244.X

A network of immediate early gene products propagates subtle differences in mitogen-activated protein kinase signal amplitude and duration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00244.X

Sustained activation of extracellular-signal-regulated kinase 1 (ERK1) is required for the continued expression of cyclin D1 in G1 phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00244.X

Sustained MAP kinase activation is required for the expression of cyclin D1, p21Cip1 and a subset of AP-1 proteins in CCL39 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00244.X

Mouse JunD negatively regulates fibroblast growth and antagonizes transformation by ras.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00244.X

Phosphorylation of three regulatory serines of Tob by Erk1 and Erk2 is required for Ras-mediated cell proliferation and transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00244.X

Mice lacking a transcriptional corepressor Tob are predisposed to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00244.X

JunD protects cells from p53-dependent senescence and apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00244.X

Mouse development and cell proliferation in the absence of D-cyclins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00244.X

Mammalian cells cycle without the D-type cyclin-dependent kinases Cdk4 and Cdk6

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00244.X

Leukemia inhibitory factor induces DNA synthesis in Swiss mouse 3T3 cells independently of cyclin D1 expression through a mechanism involving MEK/ERK1/2 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00244.X

The phosphatidylinositol 3-Kinase AKT pathway in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00244.X

Phosphoinositide 3-kinase in disease: timing, location, and scaffolding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00244.X

High-Intensity Raf Signal Causes Cell Cycle Arrest Mediated by p21Cip1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00244.X

Raf-Induced Proliferation or Cell Cycle Arrest Is Determined by the Level of Raf Activity with Arrest Mediated by p21Cip1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00244.X

Ras promotes p21(Waf1/Cip1) protein stability via a cyclin D1-imposed block in proteasome-mediated degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00244.X

Cooperative regulation of the cell division cycle by the protein kinases RAF and AKT

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00244.X

Centaurin-alpha1 is a phosphatidylinositol 3-kinase-dependent activator of ERK1/2 mitogen-activated protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00244.X

BRAF mutation predicts sensitivity to MEK inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00244.X

Specific protection against breast cancers by cyclin D1 ablation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00244.X

The expression of Sprouty1, an inhibitor of fibroblast growth factor signal transduction, is decreased in human prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00244.X

The ras/mitogen-activated protein kinase pathway inhibitor and likely tumor suppressor proteins, sprouty 1 and sprouty 2 are deregulated in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00244.X

Epigenetic inactivation of the human sprouty2 (hSPRY2) homologue in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00244.X

Sprouty 2, an inhibitor of mitogen-activated protein kinase signaling, is down-regulated in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00244.X

Sprouty4, a suppressor of tumor cell motility, is down regulated by DNA methylation in human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00244.X

SPRY2 is an inhibitor of the ras/extracellular signal-regulated kinase pathway in melanocytes and melanoma cells with wild-type BRAF but not with the V599E mutant

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00244.X

Effect of common B-RAF and N-RAS mutations on global gene expression in melanoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00244.X

10.1111/J.1349-7006.2006.00244.X

21 January 2018

Identifiers

DOI

1 reference

14 August 2017

1 reference